Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.670
-0.090 (-2.39%)
At close: Apr 28, 2026, 4:00 PM EDT
3.740
+0.070 (1.91%)
After-hours: Apr 28, 2026, 7:16 PM EDT
Apyx Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -11.21 | -23.46 | -18.71 | -23.18 | -15.17 | |
| Depreciation & Amortization | 0.66 | 0.6 | 0.69 | 0.89 | 0.9 | |
| Loss (Gain) From Sale of Assets | 0.02 | 0.01 | -2.53 | 0.08 | 0.05 | |
| Stock-Based Compensation | 2 | 4.01 | 5.11 | 6.7 | 5.09 | |
| Provision & Write-off of Bad Debts | 0.42 | 0.4 | 0.28 | 0.32 | 0.13 | |
| Other Operating Activities | 1.7 | 1.64 | 4.37 | 0.14 | 0.4 | |
| Change in Accounts Receivable | -1.32 | -2.04 | -3.57 | 1.92 | -4.9 | |
| Change in Inventory | -1.07 | 2.26 | 1.46 | -5.57 | -2.86 | |
| Change in Accounts Payable | 0.36 | -0.06 | 0.03 | 0.07 | 1.15 | |
| Change in Income Taxes | - | - | 7.55 | 0.1 | 0.01 | |
| Change in Other Net Operating Assets | 0.45 | -1.41 | 0.09 | -1.73 | 4.75 | |
| Operating Cash Flow | -8 | -18.05 | -5.25 | -20.28 | -10.45 | |
| Capital Expenditures | -1.11 | -0.72 | -0.53 | -1.01 | -0.72 | |
| Sale of Property, Plant & Equipment | - | - | 7.27 | - | - | |
| Investing Cash Flow | -1.11 | -0.72 | 6.73 | -1.01 | -0.72 | |
| Long-Term Debt Issued | - | - | 43.47 | - | - | |
| Long-Term Debt Repaid | -0.02 | -0.02 | -11.07 | -0.15 | -0.24 | |
| Total Debt Repaid | -0.02 | -0.02 | -11.07 | -0.15 | -0.24 | |
| Net Debt Issued (Repaid) | -0.02 | -0.02 | 32.41 | -0.15 | -0.24 | |
| Issuance of Common Stock | 9.79 | 7 | 0.09 | 0.37 | 0.07 | |
| Other Financing Activities | -0.19 | -0.24 | -0.33 | - | 0.2 | |
| Financing Cash Flow | 9.58 | 6.75 | 32.17 | 0.22 | 0.02 | |
| Foreign Exchange Rate Adjustments | -0.47 | 0.11 | -0.19 | 0.4 | 0.1 | |
| Net Cash Flow | -0 | -11.91 | 33.46 | -20.68 | -11.05 | |
| Free Cash Flow | -9.12 | -18.77 | -5.78 | -21.29 | -11.17 | |
| Free Cash Flow Margin | -17.25% | -39.02% | -11.04% | -47.83% | -23.03% | |
| Free Cash Flow Per Share | -0.22 | -0.53 | -0.17 | -0.62 | -0.33 | |
| Cash Interest Paid | 4.64 | 4.75 | 1.94 | 0.02 | 0.01 | |
| Cash Income Tax Paid | 0.26 | 0.38 | 0.33 | 0.13 | 0.11 | |
| Levered Free Cash Flow | -7.11 | -11.58 | -1.9 | -5.54 | -5.33 | |
| Unlevered Free Cash Flow | -3.61 | -7.88 | -0.35 | -5.53 | -5.33 | |
| Change in Working Capital | -1.59 | -1.25 | 5.54 | -5.22 | -1.84 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.